Annual SGA
$10.02 M
-$1.52 M-13.21%
December 31, 2023
Summary
- As of February 7, 2025, MBRX annual SGA is $10.02 million, with the most recent change of -$1.52 million (-13.21%) on December 31, 2023.
- During the last 3 years, MBRX annual SGA has risen by +$3.23 million (+47.63%).
- MBRX annual SGA is now -13.21% below its all-time high of $11.54 million, reached on December 31, 2022.
Performance
MBRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.17 M
+$108.00 K+5.23%
September 30, 2024
Summary
- As of February 7, 2025, MBRX quarterly SGA is $2.17 million, with the most recent change of +$108.00 thousand (+5.23%) on September 30, 2024.
- Over the past year, MBRX quarterly SGA has dropped by -$221.00 thousand (-9.24%).
- MBRX quarterly SGA is now -32.04% below its all-time high of $3.20 million, reached on June 30, 2022.
Performance
MBRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$560.56 M
-$30.15 M-5.68%
September 30, 2024
Summary
- As of February 7, 2025, MBRX TTM SGA is -$560.56 million, with the most recent change of -$30.15 million (-5.68%) on September 30, 2024.
- Over the past year, MBRX TTM SGA has dropped by -$570.33 million (-5836.35%).
- MBRX TTM SGA is now -51774.51% below its all-time high of -$1.08 million.
Performance
MBRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MBRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.2% | -9.2% | -5836.4% |
| 3 y3 years | +47.6% | -12.8% | -5171.1% |
| 5 y5 years | +91.6% | -12.8% | -5171.1% |
MBRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.2% | +19.4% | -32.0% | +9.0% | -107.8% | at low |
| 5 y | 5-year | -13.2% | +58.7% | -32.0% | +38.9% | -308.2% | at low |
| alltime | all time | -13.2% | +320.7% | -32.0% | +609.8% | <-9999.0% | at low |
Moleculin Biotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.17 M(+5.2%) | $8.88 M(-5.0%) |
| Jun 2024 | - | $2.06 M(-13.7%) | $9.34 M(-4.4%) |
| Mar 2024 | - | $2.39 M(+6.3%) | $9.77 M(-2.4%) |
| Dec 2023 | $10.02 M(-13.2%) | $2.25 M(-14.5%) | $10.02 M(-5.5%) |
| Sep 2023 | - | $2.63 M(+5.7%) | $10.60 M(-4.1%) |
| Jun 2023 | - | $2.49 M(-5.5%) | $11.05 M(-6.0%) |
| Mar 2023 | - | $2.64 M(-7.1%) | $11.76 M(+1.9%) |
| Dec 2022 | $11.54 M(+37.6%) | $2.84 M(-8.1%) | $11.54 M(+7.9%) |
| Sep 2022 | - | $3.09 M(-3.4%) | $10.70 M(+11.1%) |
| Jun 2022 | - | $3.20 M(+32.0%) | $9.63 M(+8.6%) |
| Mar 2022 | - | $2.42 M(+21.6%) | $8.87 M(+5.8%) |
| Dec 2021 | $8.39 M(+23.6%) | $1.99 M(-1.4%) | $8.39 M(+4.1%) |
| Sep 2021 | - | $2.02 M(-17.0%) | $8.06 M(+4.7%) |
| Jun 2021 | - | $2.43 M(+25.5%) | $7.70 M(+11.3%) |
| Mar 2021 | - | $1.94 M(+16.6%) | $6.91 M(+1.9%) |
| Dec 2020 | $6.79 M | $1.66 M(+0.2%) | $6.79 M(+1.5%) |
| Sep 2020 | - | $1.66 M(+0.4%) | $6.69 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $1.65 M(-8.7%) | $6.70 M(+2.6%) |
| Mar 2020 | - | $1.81 M(+15.7%) | $6.53 M(+3.5%) |
| Dec 2019 | $6.31 M(+20.7%) | $1.56 M(-6.5%) | $6.31 M(+3.2%) |
| Sep 2019 | - | $1.67 M(+12.7%) | $6.12 M(+7.4%) |
| Jun 2019 | - | $1.48 M(-6.7%) | $5.69 M(+4.9%) |
| Mar 2019 | - | $1.59 M(+16.1%) | $5.43 M(+3.8%) |
| Dec 2018 | $5.23 M(+27.8%) | $1.37 M(+9.8%) | $5.23 M(+5.4%) |
| Sep 2018 | - | $1.25 M(+2.3%) | $4.96 M(-1.8%) |
| Jun 2018 | - | $1.22 M(-12.4%) | $5.05 M(+9.1%) |
| Mar 2018 | - | $1.39 M(+26.2%) | $4.63 M(+13.3%) |
| Dec 2017 | $4.09 M(+71.8%) | $1.10 M(-17.6%) | $4.09 M(+16.2%) |
| Sep 2017 | - | $1.34 M(+67.3%) | $3.52 M(+13.3%) |
| Jun 2017 | - | $800.00 K(-5.7%) | $3.10 M(+6.2%) |
| Mar 2017 | - | $848.00 K(+59.1%) | $2.92 M(+22.8%) |
| Dec 2016 | $2.38 M | $533.00 K(-42.3%) | $2.38 M(+28.8%) |
| Sep 2016 | - | $924.00 K(+49.5%) | $1.85 M(+100.0%) |
| Jun 2016 | - | $618.00 K(+102.0%) | $924.00 K(+202.0%) |
| Mar 2016 | - | $306.00 K | $306.00 K |
FAQ
- What is Moleculin Biotech annual SGA?
- What is the all time high annual SGA for Moleculin Biotech?
- What is Moleculin Biotech annual SGA year-on-year change?
- What is Moleculin Biotech quarterly SGA?
- What is the all time high quarterly SGA for Moleculin Biotech?
- What is Moleculin Biotech quarterly SGA year-on-year change?
- What is Moleculin Biotech TTM SGA?
- What is the all time high TTM SGA for Moleculin Biotech?
- What is Moleculin Biotech TTM SGA year-on-year change?
What is Moleculin Biotech annual SGA?
The current annual SGA of MBRX is $10.02 M
What is the all time high annual SGA for Moleculin Biotech?
Moleculin Biotech all-time high annual SGA is $11.54 M
What is Moleculin Biotech annual SGA year-on-year change?
Over the past year, MBRX annual SGA has changed by -$1.52 M (-13.21%)
What is Moleculin Biotech quarterly SGA?
The current quarterly SGA of MBRX is $2.17 M
What is the all time high quarterly SGA for Moleculin Biotech?
Moleculin Biotech all-time high quarterly SGA is $3.20 M
What is Moleculin Biotech quarterly SGA year-on-year change?
Over the past year, MBRX quarterly SGA has changed by -$221.00 K (-9.24%)
What is Moleculin Biotech TTM SGA?
The current TTM SGA of MBRX is -$560.56 M
What is the all time high TTM SGA for Moleculin Biotech?
Moleculin Biotech all-time high TTM SGA is -$1.08 M
What is Moleculin Biotech TTM SGA year-on-year change?
Over the past year, MBRX TTM SGA has changed by -$570.33 M (-5836.35%)